Opioids News and Research

RSS
An opioid is a chemical that works by binding to opioid receptors, which are found principally in the central nervous system and the gastrointestinal tract. The receptors in these two organ systems mediate both the beneficial effects and the side effects of opioids.
Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

Woodcock discusses FDA's ongoing initiative to reduce preventable harm from medication use

Physicians fail to provide pain treatment for fear of prescription drug abuse

Physicians fail to provide pain treatment for fear of prescription drug abuse

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

Positive results from DURECT's Phase IIb POSIDUR clinical trial for post-surgical pain

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

BDSI's BEMA Buprenorphine Phase 2 study meets primary efficacy endpoint

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Pharmacy directors willing to cover tanezumab at lower prices

Pharmacy directors willing to cover tanezumab at lower prices

Update on proposed transaction that will lead to the merger of Cytopia into YM BioSciences provided

Update on proposed transaction that will lead to the merger of Cytopia into YM BioSciences provided

YM BioSciences announces results of collaborative antibody development program

YM BioSciences announces results of collaborative antibody development program

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

Deaths from opioid use in Ontario have doubled, according to new study

Deaths from opioid use in Ontario have doubled, according to new study

Opioids can be a safe and effective treatment for pain, shows study

Opioids can be a safe and effective treatment for pain, shows study

FDA approves two New Drug Applications

FDA approves two New Drug Applications

Genetic differences determine intensity of people's responses to social rejection

Genetic differences determine intensity of people's responses to social rejection

American Pain Society supports FDA drug disposal guidelines

American Pain Society supports FDA drug disposal guidelines

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Javelin Pharmaceuticals submits an NDA for Dyloject Injection

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

Phosphagenics commences Phase 1B clinical trial of its oxycodone/TPM transdermal patch systems

New nursing guideline to enhance improved care for MMT clients

New nursing guideline to enhance improved care for MMT clients

Masimo Rainbow SET Acoustic Monitoring receives FDA clearance

Masimo Rainbow SET Acoustic Monitoring receives FDA clearance

New article discusses the balance between pain management and drug safety

New article discusses the balance between pain management and drug safety

Study examines temporal association between media coverage and opioid-related deaths

Study examines temporal association between media coverage and opioid-related deaths

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.